Home  >  Products  >  CD226 (CD226 molecule ) Blocking Peptide (the C terminal of CD226)(100ug)
CD226 (CD226 molecule ) Blocking Peptide (the C terminal of CD226)(100ug)

CD226 (CD226 molecule ) Blocking Peptide (the C terminal of CD226)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CD226 Antibody (ARP63749_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63749
Size: 100ug
Weight: 38kDa
Gene: 10666
Format: Lyophilized powder
Target: This gene encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation.
Alternative names: DNAM-1; DNAM1; PTA1; TLiSA1
See Full Product Listings >